|
FY2014
12 months to Oct 31, 2014
|
FY2013
12 months to Oct 31, 2013
|
FY2012
12 months to Oct 31, 2012
|
|
|---|---|---|---|
| Revenues | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling, general and administrative | |||
| Research and development | |||
| Termination of oncology agreement - net | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income/(expenses): | |||
| Note discount amortization | |||
| Interest expense | |||
| Other income/(expenses) | |||
| Total other income/(expense) | |||
| Net loss | |||
| Basic net loss per common share (in Dollars per Share) | |||
| Basic weighted average common shares outstanding (in Shares) |
Loading...
